Browsing Tag
psychedelics
3 posts
How Psyence BioMed’s new pharmaceutical-grade ibogaine supply chain reshapes addiction-therapy markets
Psyence Biomedical Ltd., PsyLabs, ibogaine, psychedelics, substance use disorder, pharmaceutical manufacturing
Is bretisilocin the Cymbalta of psychedelic‑inspired psychiatry? What AbbVie’s $1.2 bn bet reveals
AbbVie’s $1.2 B deal for bretisilocin could signal the next era of antidepressants. Could this short‑acting compound become the Cymbalta of psychedelic‑inspired psychiatry?
Are short-acting psychedelics the next big bet in mental health? What pharma’s billion-dollar moves suggest
Are short-acting psychedelics the future of psychiatry? Pharma’s billion-dollar bets say yes. We explore what’s behind the new wave of scalable mental health drugs.